SCHEMBL29139548

SCHEMBL29139548

O=[N+]([O-])c1cc(Cl)ccc1CNCCCO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
ACLY P53396 1/20 0.42
MAPT P10636 5/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
ALDH1A1 P00352 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
APP P05067 1/20 0.41
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3180680 0.84 CXCR4 (0.45) CXCR4NPC1RAB9AHPGDCYP1A2
SCHEMBL358223 0.81 ACLY (0.52) NPC1RAB9AHPGDCYP1A2CYP3A4
SCHEMBL2578117 0.80 ALDH1A1 (0.55) NPC1RAB9AHPGDCYP3A4CYP2C19
SCHEMBL6775866 0.79 CYP1A2 (0.49) NPC1RAB9AHPGDCYP1A2CYP3A4
SCHEMBL29836060 0.79 MAPK1 (0.52) NPC1RAB9AHPGDCYP1A2CYP3A4
SCHEMBL535457 0.79 MAPK1 (0.52) NPC1RAB9AHPGDCYP1A2CYP3A4
Ammonia Solution, Strong SCHEMBL28325235 0.77 MAPK1 (0.50) NPC1RAB9AHPGDCYP1A2CYP3A4
SCHEMBL2796146 0.77 MAPT (0.66) CYP1A2CYP3A4CYP2C19MAPTALDH1A1
SCHEMBL29580293 0.77 MAPT (0.66) CYP1A2CYP3A4CYP2C19MAPTALDH1A1
SCHEMBL67536 0.77 MAPK1 (0.53) NPC1RAB9AHPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116891484-A Condensed ring compound, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-10-17 CN disclosed